Key role of ERK pathway signaling in lupus

References

• Kotzin BL. Systemic lupus erythematosus. Cell. 1996; 85 3: 303–306.
   PubMed Web of Science ®Google Scholar
• Cobb MH. MAP kinase pathways. Prog Biophys Mol Biol. 1999; 71 3–4: 479–500.
   PubMed Web of Science ®Google Scholar
• Hommes DW, Peppelenbosch MP, van Deventer SJ. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut. 2003; 52 1: 144–151.
   PubMed Web of Science ®Google Scholar
• Ueda Y, Hirai S, Osada S, Suzuki A, Mizuno K, Ohno S. Protein kinase C activates the MEK–ERK pathway in a manner independent of Ras and dependent on Raf. J Biol Chem. 1996; 271 38: 23512–23519.
   PubMed Web of Science ®Google Scholar
• Ferrell JEJr. Tripping the switch fantastic: How a protein kinase cascade can convert graded inputs into switch-like outputs. Trends Biochem Sci. 1996; 21 12: 460–466.
   PubMedGoogle Scholar
• Cantrell D. T cell antigen receptor signal transduction pathways. Annu Rev Immunol. 1996; 14:259–274.
   PubMed Web of Science ®Google Scholar
• Graves JD, Downward J, Izquierdo-Pastor M, Rayter S, Warne PH, Cantrell DA. The growth factor IL-2 activates p21ras proteins in normal human T lymphocytes. J Immunol. 1992; 148 8: 2417–2422.
   PubMedGoogle Scholar
• Barnard D, Diaz B, Clawson D, Marshall M. Oncogenes, growth factors and phorbol esters regulate Raf-1 through common mechanisms. Oncogene. 1998; 17 12: 1539–1547.
   PubMedGoogle Scholar
• Izquierdo M, Downward J, Graves JD, Cantrell DA. Role of protein kinase C in T-cell antigen receptor regulation of p21ras: Evidence that two p21ras regulatory pathways coexist in T cells. Mol Cell Biol. 1992; 12 7: 3305–3312.
   PubMedGoogle Scholar
• Marais R, Light C, Mason C, Peterson H, Olson MF, Marshall CJ. Requirement of Ras–GTP–Raf complexes for activation of Raf-1 by protein kinase C. Science. 1998; 280 5360: 109–112.
   PubMed Web of Science ®Google Scholar
• Marks RE, Ho AW, Rivas F, Marshall E, Janardhan S, Gajewski TF. Differential Ras signaling via the antigen receptor and IL-2 receptor in primary T lymphocytes. Biochem Biophys Res Commun. 2003; 312 3: 691–696.
   PubMedGoogle Scholar
• Sun Z, Arendt CW, Ellmeier W, Schaeffer EM, Sunshine MJ, Gandhi L, . PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature. 2000; 404 6776: 402–407.
   PubMedGoogle Scholar
• Werlen G, Jacinto E, Xia Y, Karin M. Calcineurin preferentially synergizes with PKC-theta to activate JNK and IL-2 promoter in T lymphocytes. EMBO J. 1998; 17 11: 3101–3111.
   PubMed Web of Science ®Google Scholar
• Puente LG, Stone JC, Ostergaard HL. Evidence for protein kinase C-dependent and -independent activation of mitogen-activated protein kinase in T cells: Potential role of additional diacylglycerol binding proteins. J Immunol. 2000; 165 12: 6865–6871.
   PubMedGoogle Scholar
• Cantrell DA. GTPases and T cell activation. Immunol Rev. 2003; 192:122–130.
   PubMed Web of Science ®Google Scholar
• Roose JP, Mollenauer M, Gupta VA, Stone J, Weiss A. A diacylglycerol-protein kinase C-RasGRP1 pathway directs Ras activation upon antigen receptor stimulation of T cells. Mol Cell Biol. 2005; 25 11: 4426–4441.
   PubMedGoogle Scholar
• Fernandez DR, Telarico T, Bonnilla E, Li Q, Banerjee S, Middleton FA, . Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation. J Immunol. 2009; 182 4: 2063–2073.
   PubMed Web of Science ®Google Scholar
• Fernandez D, Perl A. Metabolic control of T cell activation and death in SLE. Autoimmun Rev. 2009; 8 3: 184–189.
   PubMedGoogle Scholar
• Quddus J, Johnson KL, Gavalchin J, Amento E, Chrisp CE, Yung RL, . Treating activated CD4+T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest. 1993; 92 1: 38–53.
   PubMedGoogle Scholar
• Mi XB, Zeng FQ. Hypomethylation of interleukin-4 and -6 promoters in T cells from systemic lupus erythematosus patients. Acta Pharmacol Sin. 2008; 29 1: 105–112.
   PubMedGoogle Scholar
• Sunahori K, Juang YT, Tsokos GC. Methylation status of CpG islands flanking a cAMP response element motif on the protein phosphatase 2Ac alpha promoter determines CREB binding and activity. J Immunol. 2009; 182 3: 1500–1508.
   PubMed Web of Science ®Google Scholar
• Richardson B. Primer: Epigenetics of autoimmunity. Nat Clin Pract Rheumatol. 2007; 3 9: 521–527.
   PubMedGoogle Scholar
• Deng C, Yang J, Scott J, Hanash S, Richardson BC. Role of the Ras–MAPK signaling pathway in the DNA methyltransferase response to DNA hypomethylation. Biol Chem. 1998; 379 8–9: 1113–1120.
   PubMedGoogle Scholar
• MacLeod AR, Rouleau J, Szyf M. Regulation of DNA methylation by the Ras signaling pathway. J Biol Chem. 1995; 270 19: 11327–11337.
   PubMed Web of Science ®Google Scholar
• Yang J, Deng C, Hemati N, Hanash SM, Richardson BC. Effect of mitogenic stimulation and DNA methylation on human T cell DNA methyltransferase expression and activity. J Immunol. 1997; 159 3: 1303–1309.
   PubMedGoogle Scholar
• Cornacchia E, Golbus J, Maybaum J, Strahler J, Hanash S, Richardson BC. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J Immunol. 1988; 140 7: 2197–2200.
   PubMed Web of Science ®Google Scholar
• Scheinbart LS, Johnson MA, Gross LA, Edelstein SR, Richardson BC. Procainamide inhibits DNA methyltransferase in a human T cell line. J Rheumatol. 1991; 18 4: 530–534.
   PubMedGoogle Scholar
• Deng C, Lu Q, Zhang Z, Rao T, Attwood J, Yung R, Richardson BC. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum. 2003; 48 3: 746–756.
   PubMed Web of Science ®Google Scholar
• Deng C, Kaplan MJ, Yang J, Ray D, Zhang Z, McCune WJ, . Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum. 2001; 44 2: 397–407.
   PubMedGoogle Scholar
• Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 1990; 33 11: 1665–1673.
   PubMed Web of Science ®Google Scholar
• Richardson BC, Liebling MR, Hudson JL. CD4+cells treated with DNA methylation inhibitors induce autologous B cell differentiation. Clin Immunol Immunopathol. 1990; 55 3: 368–381.
   PubMedGoogle Scholar
• Mor A, Philips MR, Pillinger MH. The role of Ras signaling in lupus T lymphocytes: Biology and pathogenesis. Clin Immunol. 2007; 125 3: 215–223.
   PubMed Web of Science ®Google Scholar
• Cedeno S, Cifarelli DF, Blasini AM, Paris M, Placeres F, Alonso G, . Defective activity of ERK-1 and ERK-2 mitogen-activated protein kinases in peripheral blood T lymphocytes from patients with systemic lupus erythematosus: Potential role of altered coupling of Ras guanine nucleotide exchange factor hSos to adapter protein Grb2 in lupus T cells. Clin Immunol. 2003; 106 1: 41–49.
   PubMed Web of Science ®Google Scholar
• Hickman SP, Yang J, Thomas RM, Wells AD, Turka LA. Defective activation of protein kinase C and Ras–ERK pathways limits IL-2 production and proliferation by CD4+ CD25+regulatory T cells. J Immunol. 2006; 177 4: 2186–2194.
   PubMedGoogle Scholar
• Lens SM, Tesselaar K, van Oers M, van Lier R. Control of lymphocyte function through CD27–CD70 interactions. Semin Immunol. 1998; 10 6: 491–499.
   PubMedGoogle Scholar
• Oelke K, Lu Q, Richardson D, Wu A, Deng C, Hanash S, Richardson BC. Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors. Arthritis Rheum. 2004; 50 6: 1850–1860.
   PubMed Web of Science ®Google Scholar
• Lu Q, Wu A, Richardson BC. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J Immunol. 2005; 174 10: 6212–6219.
   PubMed Web of Science ®Google Scholar
• Sawalha AH, Jeffries M, Webb R, Lu Q, Gorelik G, Ray D, . Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients. Genes Immun. 2008; 9 4: 368–378.
   PubMed Web of Science ®Google Scholar
• Gorelik G, Fang JY, Wu A, Sawalha AH, Richardson B. Impaired T cell protein kinase C delta activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus. J Immunol. 2007; 179 8: 5553–5563.
   PubMed Web of Science ®Google Scholar
• Miyamoto A, . Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature. 2002; 416 6883: 865–869.
   PubMed Web of Science ®Google Scholar